Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
CB1 antagonist 1
Cat. No.:
OB0425LY-308
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
CB1 antagonist 1 is a class of compounds that antagonize cannabinoid type 1 receptors (CB1) and possess the potential to reduce appetite and promote fat metabolism.
Synonyms:
CB1 antagonist 1; 890037-68-0; CB1 antagonist-1
CAS No.:
890037-68-0
Compound CID:
57404849
Formula:
C26H22Cl2N4
Formula Weight:
461.39
Specification
Target:
Cannabinoid receptor
Pathway:
GPCR/G protein; Neuronal signaling
Storage:
Storage at -20°C.
Applications:
CB1 antagonist 1 can be used in therapeutic studies for obesity and related metabolic diseases.
